LUPUS NEPHRITIS (LN)

Clinical trials for LUPUS NEPHRITIS (LN) explained in plain language.

Never miss a new study

Get alerted when new LUPUS NEPHRITIS (LN) trials appear

Sign up with your email to follow new studies for LUPUS NEPHRITIS (LN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 13 Not yet recruiting 5 Not yet finished but already full! 1

Could a diabetes drug shield kidneys from lupus damage?

Disease control Ongoing

This phase 2 trial tests whether dapagliflozin, a drug already used for diabetes and chronic kidney disease, can slow kidney damage in people with lupus nephritis. Lupus nephritis is a serious complication of lupus that causes kidney inflammation and can lead to chronic kidney di…

Matched conditions: LUPUS NEPHRITIS (LN)

Phase: PHASE1, PHASE2 • Sponsor: Hospital Civil Juan I. Menchaca • Aim: Disease control

Last updated Jul 02, 2026 01:00 UTC

LUPUS NEPHRITIS (LN)

Get alerted when new LUPUS NEPHRITIS (LN) trials appear

Could a diabetes drug shield kidneys from lupus damage?